Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-29 @ 11:45 AM
Study NCT ID:
NCT01168232
Status:
COMPLETED
Last Update Posted:
2019-08-08
First Post:
2010-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-22
First Submit QC Date:
None
Study First Post Date:
2010-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-19
Results First Submit QC Date:
None
Results First Post Date:
2017-01-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-06
Last Update Post Date:
2019-08-08
Last Update Post Date Type:
ACTUAL